Trigger Point Injections and Pelvic Rehabilitation for the Treatment of Pelvic Floor Myalgia and Sexual Pain
Status unconfirmed · Phase 4
Conditions studied: Dyspareunia
In brief
The purpose of this study is to evaluate which treatment option for pelvic floor pain allows for improved sexual function.
Key facts
- Study ID
- NCT02022722
- Run by
- University of Cincinnati
- People needed
- 36
- Starts
- 2013-08-01
- Expected to finish
- 2014-06-01
- Last updated by the study team
- 2013-12-30
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- pelvic pain
- pelvic floor myalgia
- dyspareunia
- female
- age > 18 years
You may not qualify if…
- interstitial cystitis
- vaginal lesions / ulcerations
- prior trigger point injections in the past 6 months
- prior pelvic rehabilitation in the past 6 months
- laparoscopically documented endometriosis / pelvic adhesions or adhesive disease
- documented pelvic inflammatory disease identified within the past 6 months
- documented sexually transmitted disease within the past 6 months
Where it is running
- Division of Urogynecology, University of Cincinnati Medical Center — Cincinnati, Ohio, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.